We are delighted to announce that our latest whitepaper, in collaboration with Back Bay Life Science Advisors: 'Microbiome Medicinal Products: Concept to Commercial', is now available to read and download.

This whitepaper delves into the dynamic field of live biotherapeutic drug development, which over the last decade has emerged from an area of intriguing pre-clinical and clinical data to a space with multiple licensed medicines. This paper offers a comprehensive analysis of the current regulatory landscape, investment trends, and developmental strides in areas extending beyond gut disease.

Read and Download now: https://www.scendea.com/microbiome-medicinal-products